These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 15520407)

  • 1. FRG2, an FSHD candidate gene, is transcriptionally upregulated in differentiating primary myoblast cultures of FSHD patients.
    Rijkers T; Deidda G; van Koningsbruggen S; van Geel M; Lemmers RJ; van Deutekom JC; Figlewicz D; Hewitt JE; Padberg GW; Frants RR; van der Maarel SM
    J Med Genet; 2004 Nov; 41(11):826-36. PubMed ID: 15520407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.
    Winokur ST; Chen YW; Masny PS; Martin JH; Ehmsen JT; Tapscott SJ; van der Maarel SM; Hayashi Y; Flanigan KM
    Hum Mol Genet; 2003 Nov; 12(22):2895-907. PubMed ID: 14519683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
    Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
    BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotype-phenotype study in an FSHD family with a proximal deletion encompassing p13E-11 and D4Z4.
    Deak KL; Lemmers RJ; Stajich JM; Klooster R; Tawil R; Frants RR; Speer MC; van der Maarel SM; Gilbert JR
    Neurology; 2007 Feb; 68(8):578-82. PubMed ID: 17229919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cell cultures and tissues.
    Tsien F; Sun B; Hopkins NE; Vedanarayanan V; Figlewicz D; Winokur S; Ehrlich M
    Mol Genet Metab; 2001 Nov; 74(3):322-31. PubMed ID: 11708861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy.
    Osborne RJ; Welle S; Venance SL; Thornton CA; Tawil R
    Neurology; 2007 Feb; 68(8):569-77. PubMed ID: 17151338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q.
    Jiang G; Yang F; van Overveld PG; Vedanarayanan V; van der Maarel S; Ehrlich M
    Hum Mol Genet; 2003 Nov; 12(22):2909-21. PubMed ID: 14506132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers.
    Butz M; Koch MC; Müller-Felber W; Lemmers RJ; van der Maarel SM; Schreiber H
    J Neurol; 2003 Aug; 250(8):932-7. PubMed ID: 12928911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DUX4 promotes transcription of FRG2 by directly activating its promoter in facioscapulohumeral muscular dystrophy.
    Thijssen PE; Balog J; Yao Z; Pham TP; Tawil R; Tapscott SJ; Van der Maarel SM
    Skelet Muscle; 2014; 4():19. PubMed ID: 25789155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD.
    de Greef JC; Wohlgemuth M; Chan OA; Hansson KB; Smeets D; Frants RR; Weemaes CM; Padberg GW; van der Maarel SM
    Neurology; 2007 Sep; 69(10):1018-26. PubMed ID: 17785671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolutionary genomic remodelling of the human 4q subtelomere (4q35.2).
    Bodega B; Cardone MF; Müller S; Neusser M; Orzan F; Rossi E; Battaglioli E; Marozzi A; Riva P; Rocchi M; Meneveri R; Ginelli E
    BMC Evol Biol; 2007 Mar; 7():39. PubMed ID: 17359533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Krüppel-like factor 15 as a molecular link between myogenic factors and a chromosome 4q transcriptional enhancer implicated in facioscapulohumeral dystrophy.
    Dmitriev P; Petrov A; Ansseau E; Stankevicins L; Charron S; Kim E; Bos TJ; Robert T; Turki A; Coppée F; Belayew A; Lazar V; Carnac G; Laoudj D; Lipinski M; Vassetzky YS
    J Biol Chem; 2011 Dec; 286(52):44620-31. PubMed ID: 21937448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of 4q35.2 to the nuclear periphery: is FSHD a nuclear envelope disease?
    Masny PS; Bengtsson U; Chung SA; Martin JH; van Engelen B; van der Maarel SM; Winokur ST
    Hum Mol Genet; 2004 Sep; 13(17):1857-71. PubMed ID: 15238509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic analysis of human chromosome 10q and 4q telomeres suggests a common origin.
    van Geel M; Dickson MC; Beck AF; Bolland DJ; Frants RR; van der Maarel SM; de Jong PJ; Hewitt JE
    Genomics; 2002 Feb; 79(2):210-7. PubMed ID: 11829491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes.
    Lyle R; Wright TJ; Clark LN; Hewitt JE
    Genomics; 1995 Aug; 28(3):389-97. PubMed ID: 7490072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The possible place of autologus cell therapy in facioscapulohumeral muscular dystrophy].
    Desnuelle C; Sacconi S; Marolleau JP; Larghero J; Vilquin JT
    Bull Acad Natl Med; 2005 Apr; 189(4):697-713; discussion 713-4. PubMed ID: 16245686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The genes encoding for D4Z4 binding proteins HMGB2, YY1, NCL, and MYOD1 are excluded as candidate genes for FSHD1B.
    Bastress KL; Stajich JM; Speer MC; Gilbert JR
    Neuromuscul Disord; 2005 Apr; 15(4):316-20. PubMed ID: 15792872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new dosage test for subtelomeric 4;10 translocations improves conventional diagnosis of facioscapulohumeral muscular dystrophy (FSHD).
    van der Maarel SM; Deidda G; Lemmers RJ; Bakker E; van der Wielen MJ; Sandkuijl L; Hewitt JE; Padberg GW; Frants RR
    J Med Genet; 1999 Nov; 36(11):823-8. PubMed ID: 10544225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular diagnosis of facioscapulohumeral muscular dystrophy.
    Upadhyaya M; Cooper DN
    Expert Rev Mol Diagn; 2002 Mar; 2(2):160-71. PubMed ID: 11962336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A functional role for 4qA/B in the structural rearrangement of the 4q35 region and in the regulation of FRG1 and ANT1 in facioscapulohumeral dystrophy.
    Pirozhkova I; Petrov A; Dmitriev P; Laoudj D; Lipinski M; Vassetzky Y
    PLoS One; 2008; 3(10):e3389. PubMed ID: 18852887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.